Pinheiro, Laura C.
Cho, Jacklyn
Rothman, Julia
Zeng, Caroline
Wilson, Micayla
Kern, Lisa M.
Tamimi, Rulla M.
Safford, Monika M.
Funding for this research was provided by:
National Cancer Institute at the National Institutes of Health (K01 CA251645, K01 CA251645, K01 CA251645)
Article History
Received: 30 September 2022
Accepted: 20 January 2023
First Online: 2 February 2023
Declarations
:
: The study design and methodology for this study were approved by the Weill Cornell Institutional Review Board (20–03021654). Informed consent was obtained from all participants in the study. All participants provided written consent to participate in the study and publish de-identified excerpts from the interviews.
: Dr. Safford, receives salary support for investigator-initiated research from Amgen, Inc. Dr. Pinheiro receives salary support for investigator-initiated research from Pfizer. The other co-authors have no conflicts of interest to disclose.
Free to read: This content has been made available to all.